Clinical trials
Terminated Psychotic Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
94 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 5 |
| 2007 | 8 |
| 2008 | 8 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 94 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 6 |
| AstraZeneca | 5 |
| Northwestern University | 4 |
| Centre for Addiction and Mental Health | 3 |
| National Institute of Mental Health (NIMH) | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Duke University | 2 |
| Janssen-Cilag, S.A. | 2 |
| Louisiana State University Health Sciences Center Shreveport | 2 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 94 |
| Schizophrenia | 65 |
| Mental Disorders | 7 |
| Bipolar Disorder | 6 |
| Metabolic Syndrome | 3 |
| Alcoholism | 2 |
| Alzheimer Disease | 2 |
| Cognitive Dysfunction | 2 |
| Dementia | 2 |
| Hallucinations | 2 |
Trials
Showing 51 to 75 of 94. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.